Arcus Biosciences, Inc.RCUSNYSE
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank78
3Y CAGR+33.1%
5Y CAGR+101.2%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+33.1%/yr
vs +27.7%/yr prior
5Y CAGR
+101.2%/yr
Recent deceleration
Acceleration
+5.4pp
Accelerating
Percentile
P78
Within normal range
vs 5Y Ago
33x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $33.00M | -29.8% |
| 2024 | $47.00M | +20.5% |
| 2023 | $39.00M | +178.6% |
| 2022 | $14.00M | +1300.0% |
| 2021 | $1.00M | 0.0% |
| 2020 | $1.00M | -75.0% |
| 2019 | $4.00M | -24.0% |
| 2018 | $5.26M | +1366.6% |
| 2017 | $359000.00 | +69.3% |
| 2016 | $212000.00 | - |